AzTrials
AzTrials

Cataract SenileNCT04266847

Prospective Clinical Study of Preoperative and Postoperative Unilateral Mild Cataract Patients

A study testing monofocal IOL,bifocal IOL,or trifocal IOL in people with Cataract Senile, run by Peking University Third Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This is to compare preoperative and postoperative binocular functional vision in patients with unilateral intraocular len(IOL) in one eye and mild cataract in the fellow eye. Read more about this study

Who is it for?
Ages 50 to 80 years
Conditions the study is for
Cataract Senile
What is being tested?
monofocal IOL,bifocal IOL,or trifocal IOL
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteChina
Study dates
30 Oct 2019to 1 Sep 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients who had monocular intraocular lens in one eye with mild cataract in the fellow eye ask for the cataract surgery in the fellow eye
  • Regular corneal topography and corneal astigmatism ≤ 0.75 Diopter

Who cannot join

  • Pregnant or nursing women
  • In the presence of other ocular diseases that may affect the stability of the lens capsule (pseudoexfoliation syndrome, glaucoma, traumatic cataract, Marfan syndrome, etc.)
  • In the presence of other ocular diseases that is expected to have a poor final visual acuity of worse than 0.2 logMAR after surgery (amblyopia, strabismus, keratoconus, etc.)
  • Pupil abnormality (non-reactive pupil, tonic pupils, abnormally shaped pupils, etc.)
  • Patients using systemic or ocular medication that affect visual acuity.
  • Patients with history of ocular trauma or prior ocular surgery including refractive procedures
  • Patients participating in other clinical trials during the study.

Trial locations and contacts

1 site in 1 country.

QIanqian Lan contact

+8618607711972

54283122@qq.com

China1 site, 1 recruiting
  • Peking University Third Hospital

    Beijing, Beijing Municipality, 100191

    Hong Qi, MD, doctorqihong@163.com

    Recruiting

Other trials in China

About this study

This is to compare preoperative and postoperative binocular functional vision in patients with unilateral intraocular len(IOL) in one eye and mild cataract in the fellow eye.

Read the detailed description

The subjects are the patients who underwent monocular IOL implantation before and present mild cataract in the fellow eye.Compare preoperative and postoperative the binocular functional vision and the satisfaction of patients when the patients ask for the surgery (phacoemulsification and IOLs implantation)on the fellow eye. The type of IOLs maybe according to the patients preference and the eyes condition.The subjects will be divided into three groups according to the type of the IOLs,including monofocal group,bifocal group,and trifocal group.

Conditions
Cataract Senile
Being tested
monofocal IOL,bifocal IOL,or trifocal IOL
Keywords
unilateral cataract, binocular functional vision, Multifocal Intraocular Lenses

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • monofocal IOL,bifocal IOL,or trifocal IOLDevice

    phacoemulsification and implantation of IOL.IOL may be monofocal IOL,bifocal IOL,or trifocal IOL

Study groups in NCT04266847
Study groupRoleWhat they receive
unilateral mild cataract patientsExperimentalThe patients who underwent monocular IOL implantation before and then present mild cataract in the fellow eye.
Receives: Device: monofocal IOL,bifocal IOL,or trifocal IOL

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. binocular visual acuity

    uncorrected distance visual acuity (UCVA), intermediate visual acuity, near visual acuity will be measured at 5m, 80cm and 40cm respectively. All visual acuity measurements will be conducted under photopic conditions (85 cd/m2) and at 100% contrast

    Measured: 3 months postoperatively

Secondary outcomes (5)
  1. Binocular Contrast sensitivity

    Contrast sensitivity measures will be conducted binocularly, under photopic, mesopic (5 cd/m2), photopic with glare and mesopic with glare conditions, with the OPTEC 6500 contrast sensitivity test (Stereo Optical, USA). Contrast sensitivity will be evaluated at five spatial frequencies (1.5, 3, 6, 12, and 18 cycles per degree [cpd]). Patients will be allowed 5 minutes to adapt to each illumination level before testing

    Measured: 3 months postoperatively

  2. Binocular Defocus Curve

    Binocular defocus curves will be obtained in all patients, positioned at 5m under photopic (>85 cd/m 2 ) condition to measure the visual acuity with each defocus lens, representing the consecutive visual function of each eye. Negative lenses were added in 0.50 D steps and the visual acuity will be recorded for each type of defocus level. The procedure will be then repeated but with positive lenses. The range of defocus evaluated is from -4.00D to +2.00D.

    Measured: 3 months postoperatively

  3. stereopsis

    Use block diagram of random-spot synoptophore to observe long distance stereopsis vision and yan's stereogram to observe short distance stereopsis vision.

    Measured: 3 months postoperatively

  4. Fusion function

    The fusion function of perception and movement (convergence and divergence)will be examined with a synoptophore.

    Measured: 3 months postoperatively

  5. Subjective visual quality

    Photic phenomena (score according to severity,0~4, higher scores mean worse)and spectacle dependence percentages will be evaluated by questionnaire.

    Measured: 3 months postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Feb 2020
  2. Study start30 Oct 2019
  3. Primary completion1 Jun 2020 (estimated)
  4. Study completion1 Sep 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04266847
Sponsor's protocol ID
20191127
Status last verified
Feb 2020
First submitted
29 Nov 2019
Last updated
12 Feb 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing monofocal IOL,bifocal IOL,or trifocal IOL in people with Cataract Senile, run by Peking University Third Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact QIanqian Lan (+8618607711972, 54283122@qq.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

binocular visual acuity (time frame: 3 months postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Feb 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in